AU2001259062A1 - Compositions and methods for the therapy and diagnosis of lung cancer - Google Patents

Compositions and methods for the therapy and diagnosis of lung cancer

Info

Publication number
AU2001259062A1
AU2001259062A1 AU2001259062A AU5906201A AU2001259062A1 AU 2001259062 A1 AU2001259062 A1 AU 2001259062A1 AU 2001259062 A AU2001259062 A AU 2001259062A AU 5906201 A AU5906201 A AU 5906201A AU 2001259062 A1 AU2001259062 A1 AU 2001259062A1
Authority
AU
Australia
Prior art keywords
diagnosis
therapy
compositions
methods
lung cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001259062A
Inventor
Carol Yoseph Indirias
Michael J. Lodes
Raodoh Mohamath
Tongtong Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Corixa Corp
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of AU2001259062A1 publication Critical patent/AU2001259062A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
AU2001259062A 2000-04-11 2001-04-11 Compositions and methods for the therapy and diagnosis of lung cancer Abandoned AU2001259062A1 (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US19678000P 2000-04-11 2000-04-11
US60196780 2000-04-11
US21336100P 2000-06-21 2000-06-21
US60213361 2000-06-21
US22976300P 2000-09-01 2000-09-01
US60229763 2000-09-01
US23062900P 2000-09-05 2000-09-05
US60230629 2000-09-05
US23256500P 2000-09-14 2000-09-14
US60232565 2000-09-14
US25703700P 2000-12-19 2000-12-19
US60257037 2000-12-19
US26079601P 2001-01-08 2001-01-08
US60260796 2001-01-08
PCT/US2001/011859 WO2001077168A2 (en) 2000-04-11 2001-04-11 Compositions and methods for the therapy and diagnosis of lung cancer

Publications (1)

Publication Number Publication Date
AU2001259062A1 true AU2001259062A1 (en) 2001-10-23

Family

ID=27569266

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001259062A Abandoned AU2001259062A1 (en) 2000-04-11 2001-04-11 Compositions and methods for the therapy and diagnosis of lung cancer

Country Status (3)

Country Link
US (1) US20020068288A1 (en)
AU (1) AU2001259062A1 (en)
WO (1) WO2001077168A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0011439D0 (en) * 2000-05-12 2000-06-28 Novartis Res Found Cancer diagnosis and assays for screening
US7429450B2 (en) * 2001-11-15 2008-09-30 The Regents Of The University Of Michigan HIP1 cancer markers
US20060269918A1 (en) * 2002-12-04 2006-11-30 Macina Roberto A Compositions, splice variants and methods relating to colon specific genes and proteins
WO2005014818A1 (en) 2003-08-08 2005-02-17 Perseus Proteomics Inc. Gene overexpressed in cancer
EP1507004A1 (en) * 2003-08-14 2005-02-16 DKFZ Deutsches Krebsforschungszentrum Method to inhibit the propagation of an undesired cell population
US20050186577A1 (en) 2004-02-20 2005-08-25 Yixin Wang Breast cancer prognostics
US7563885B1 (en) 2004-05-24 2009-07-21 Isis Pharmaceuticals, Inc. Modulation of Tudor-SN expression
US20100093767A1 (en) * 2004-12-03 2010-04-15 Takeda San Diego, Inc. Mitotic Kinase Inhibitors
CN101283106A (en) * 2005-07-27 2008-10-08 肿瘤疗法科学股份有限公司 Method of diagnosing small cell lung cancer
US20070130694A1 (en) * 2005-12-12 2007-06-14 Michaels Emily W Textile surface modification composition
JP2010501172A (en) * 2006-08-25 2010-01-21 オンコセラピー・サイエンス株式会社 Prognostic markers and therapeutic targets for lung cancer
WO2010051314A2 (en) * 2008-10-31 2010-05-06 Abbott Laboratories Genomic classification of non-small cell lung carcinoma based on patterns of gene copy number alterations
WO2010092974A1 (en) * 2009-02-11 2010-08-19 国立大学法人東京大学 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589579A (en) * 1994-07-19 1996-12-31 Cytoclonal Pharmaceutics, Inc. Gene sequence and probe for a marker of non-small cell lung carinoma
EP1767636A3 (en) * 1998-12-23 2007-06-13 Corixa Corporation Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
WO2000073801A2 (en) * 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor

Also Published As

Publication number Publication date
US20020068288A1 (en) 2002-06-06
WO2001077168A3 (en) 2002-06-13
WO2001077168A2 (en) 2001-10-18

Similar Documents

Publication Publication Date Title
AU2001261007A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002218770A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
PL354093A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001268259A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001265296A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2001269766A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001249549A1 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
AU2002311909A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002251841A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer
AU2002251844A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU4185100A (en) Compounds for therapy and diagnosis of lung cancer and methods for their use
AU2002254482A1 (en) Compositions and methods for the therapy and diagnosis of kidney cancer
AU2001280982A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002359330A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2002303219A1 (en) Compositions and methods for the therapy and diagnosis of cancer
AU2002246519A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2001259062A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001290518A1 (en) Compositions and methods for the therapy and diagnosis of colon cancer
AU2002239431A1 (en) Compositions and methods for the therapy and diagnosis of ovarian cancer
AU2002313726A1 (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2001273149A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU5638400A (en) Compositions and methods for the therapy and diagnosis of breast cancer
AU2003230849A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001273127A1 (en) Compositions and methods for the therapy and diagnosis of lung cancer
AU2001271284A1 (en) Compositions and methods for the therapy and diagnosis of pancreatic cancer